Browse complete Report Diabetes Pipeline: Intense Activity to Meet Unmet Need

Browse all CHI Healthtech Market Research Reports

Diabetes has serious consequences if it is not well treated. In 2010, the global prevalence of diabetes was estimated to have reached 285 million and it is predicted to reach 438 million in 2030. Available agents provide imperfect control of the disease, and the medical need for better therapies is widely recognized. This report discusses:

Treatment of diabetes relies on a number of therapeutic interventions. A highly prevalent condition requiring treatment with multiple therapies generates a considerable demand for drugs. Diabetes Pipeline: Intense Activity to Meet Unmet Need begins by examining the current major products available for the treatment of diabetes and highlights the segmentation of this large market between oral and injectable treatments. In 2009, only six key players dominated the $29 billion diabetes market. We consider how near-term developments may impact the value of the global diabetes market and how new products may result in the emergence of significant new players.

This report then considers the large number of agents that are currently being developed for the treatment of diabetes, which seek to exploit a highly divergent range of potential targets. Although many of these seek to exploit new targets, a considerable number of new agents in development seek to exploit established approaches for the treatment of diabetes. The vast majority of new agents in development are directed toward the treatment of type II diabetes, with relatively few being developed principally for the treatment of type I diabetes. Almost all of the agents being developed for type I diabetes are novel insulin derivatives or formulations. Discussion of the extensive number of exploratory approaches to the development of new oral hypoglycemic agents is followed by discussion of the novel biological agents under investigation.

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004